About this trial
MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in managing stress and navigating identity, information, family, DNA-testing, and donor- or sibling-contact-related experiences.
This randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control group. The primary objectives are to assess recruitment, retention, intervention uptake and completion, data completeness, acceptability, usability, and potential unwanted effects. Changes in perceived stress, psychological wellbeing, coping, and donor-conception-related identity will be explored to assess the suitability and variability of outcome measures and to inform the design of a future trial.
Eligibility criteria
Qualifiers
Donor-conceived people
Aged 18 or over
Able to read and understand English
Provide informed consent
Disqualifiers
Not donor-conceived
Underaged ot minor
Unable to read and understand English
Unable to provide informed consent
Trial design
Treatments tested in this trial
- MyGENESIS Digital Psychoeducational Program
Treatment groups
Sponsors and collaborators
Universidade do Porto
Lead sponsor
Fundação para a Ciência e a Tecnologia
Collaborator